About GONDOLABIO SERVICECO INC
Creating new and meaningful medicines for patients with genetic diseases
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Palo Alto, California
- Founded
- 2024
- Company type
- Privately Held
- Company profile name
- GondolaBio
GondolaBio is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients living with genetic diseases. A sister company of BridgeBio Pharma, GondolaBio aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, modalities, and stages ranging from early discovery to clinical development. Its team of experienced drug discoverers, developers and innovators are committed to translating advances in genetic science into medicines that can help patients as quickly as possible.
Company locations
3160 Porter Dr, Palo Alto, California 94304, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Biotechnology
- Manufacturing
- Pharmaceutical
On LinkedIn
- Followers
- 4,135
- People linked to this company
- 71
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
300,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.